Security key
21077P108
Context Therapeutics Inc. - Common Stock (CNTX)
CUSIP: 21077P108
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 68,619,580
- Total 13F value
- $44,959,003
- Share change
- -2,786,388
- SEC-reported price per share
- $0.66
- Number of holders
- 39
- Value change
- -$1,721,044
- Number of buys
- 13
- Number of sells
- 16
- Shares outstanding
- 91,741,639
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
39
Top holders
10
CNTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Context Therapeutics Inc. SEC filings
Context Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 21077P108
Recent filing periods:
Ownership snapshot
Top reported holders of CNTX - Context Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Deep Track Capital, LP
Disclosed value leader
MPM BioImpact LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 8.3%
13D/G row: Deep Track Capital, LP
Showing 1-6 of 15 holder rows.
Quick read
Deep Track Capital, LP leads the comparable SEC ownership view at 8.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Deep Track Capital, LP's linked filing trail.
Comparable ownership
Top 5
Deep Track Capital, LP
8.3%
FRANKLIN RESOURCES INC
4.5%
Martin A. Lehr
2.1%
MPM BioImpact LLC
16%
Avidity Partners Management LP
8.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Deep Track Capital, LP |
13D/G
13F
Company
|
8.3%
|
$7,419,355
7,419,355 shares
|
$0 | 31 Mar 2025 |
| FRANKLIN RESOURCES INC |
13D/G
13F
Company
|
4.5%
|
$4,003,380
4,003,380 shares
|
$0 | 31 Mar 2025 |
| Martin A. Lehr |
13D/G
Martin Lehr
|
2.1%
|
$1,595,742
1,595,742 shares
|
$0 | 31 Dec 2024 |
| MPM BioImpact LLC |
13F
Company
|
16%
|
$9,000,000
14,705,882 shares
|
— | 31 Mar 2025 |
| Avidity Partners Management LP |
13F
Company
|
8.2%
|
$4,576,046
7,477,200 shares
|
— | 31 Mar 2025 |
| Nextech Invest, Ltd. |
13F
Company
|
8.1%
|
$4,540,645
7,419,355 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
39
Shares
68,619,580
Rows available
39
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
42
Q2 2025 holders
39
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend